Primary Care Reports – January 1, 2006

January 1, 2006

• Pharmacology Watch

  FDA Recommends Approval of Muraglitazar, But May Need To Reconsider; Which Antipsychotics Are More Dangerous?; Should CPOE Undergo Evaluation?; New Treatment for Tennis Elbow; FDA Actions

  Read more about Pharmacology Watch - Primary Care Reports – January 1, 2006

• Clinical Briefs in Primary Care supplement

  Read more about Clinical Briefs in Primary Care supplement - Primary Care Reports – January 1, 2006

• Prostate Cancer Screening Part I: The Screening Dilemma, Screening Tests, and the Role of Prostate Specific Antigen Testing

  Prostate cancer is one of the leading causes of cancer in men, both in this country and in Europe. Due to the introduction of the prostate specific antigen blood test (PSA test), the ability to diagnose prostate cancer well before signs or symptoms of the disease develop has been realized. Following its introduction, the PSA was endorsed widely and recommended by many major public health organizations as a useful screening test.

  Read more about Prostate Cancer Screening Part I: The Screening Dilemma, Screening Tests, and the Role of Prostate Specific Antigen Testing - Primary Care Reports – January 1, 2006